Success Metrics

Active Trials

4(100%)

Phase Distribution

Ph phase_1

25%

Ph phase_3

25%

Ph phase_2

50%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution4 total trials

Phase 1Safety & dosage

1(25.0%)

Phase 2Efficacy & side effects

2(50.0%)

Phase 3Large-scale testing

1(25.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(4)

Detailed Status

Recruiting3

Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

N/A

Most Advanced

Phase 3

Trials by Phase

Phase 11 (25.0%)

Phase 22 (50.0%)

Phase 31 (25.0%)

Trials by Status

active_not_recruiting125%

recruiting375%

Recent Activity

4 active trials

Showing 4 of 4

recruitingphase_2

A Research Study to Investigate the Efficacy and Safety of HRS9531 Tablets in Participants With Type 2 Diabetes Mellitus

NCT07599410

recruitingphase_3

A Clinical Study to Evaluate the Efficacy and Safety of HRS9531 Tablets in Overweight or Obese Subjects

NCT07670884

recruitingphase_1

Relative Bioavailability of First vs Second-Generation Formulations of HRS9531 Tablets in Obese or Overweight Subjects

NCT07150962

active_not_recruitingphase_2

Efficacy and Safety of HRS9531 Tablet in Obese Subjects

NCT06841445

Clinical Trials (4)

Showing 4 of 4 trials

NCT07599410Phase 2

A Research Study to Investigate the Efficacy and Safety of HRS9531 Tablets in Participants With Type 2 Diabetes Mellitus

Recruiting

NCT07670884Phase 3

A Clinical Study to Evaluate the Efficacy and Safety of HRS9531 Tablets in Overweight or Obese Subjects

Recruiting

NCT07150962Phase 1

Relative Bioavailability of First vs Second-Generation Formulations of HRS9531 Tablets in Obese or Overweight Subjects

Recruiting

NCT06841445Phase 2

Efficacy and Safety of HRS9531 Tablet in Obese Subjects

Active Not Recruiting

All 4 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 4